Target intelligence / Profile preview

Maize Atypical Receptor Kinase Interacting Kinase (ZmMIK)

Target
ZmMIK
Molecular classification
Enzyme, Kinase, MAP4K, GCK-like kinase
01

Overview

Maize Atypical Receptor Kinase Interacting Kinase (ZmMIK) is a protein kinase found in Zea mays that plays a critical role in plant signaling and development. It was originally identified as a Mitogen-Activated Protein Kinase Kinase Kinase Kinase (MAP4K) belonging to the Germinal Center Kinase (GCK) subfamily, which interacts with the Maize Atypical Receptor Kinase (MARK). This interaction is unique because MARK is a kinase-dead receptor that stimulates the catalytic activity of ZmMIK upon binding, facilitating downstream signaling related to cytokinesis and embryo development. Additionally, the name ZmMIK is also used to refer to a Maize Myo-inositol Kinase encoded by the low-phytic acid 3 (lpa3) gene, which is essential for the biosynthesis of phytic acid in seeds. While ZmMIK is a significant target for agricultural biotechnology and crop improvement, it is not considered a human therapeutic target and has no known interactions with clinical drugs.

Other names
MARK Interacting KinaseZea mays MARK Interacting KinaseMIKMaize Myo-inositol Kinase
02

Biological functions

Signal transductionCell divisionCytokinesisEmbryo developmentPhytic acid biosynthesis
03

Disease associations

Other
04

Safety considerations

Therapeutic challenge: Target is specific to Zea mays (maize) and lacks a direct human ortholog with high sequence identityAgricultural impact: Mutations in related pathways (e.g., lpa3) can lead to reduced seed viability or pleiotropic effects on plant growth

Beyond the preview

Go deeper on Maize Atypical Receptor Kinase Interacting Kinase (ZmMIK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maize Atypical Receptor Kinase Interacting Kinase (ZmMIK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call